The emerging approach of tirzepatide peptide represents a significant advance in the management of type 2 diabetes. Different to existing medications, tirzepatide targets dual pathways – GLP-1 and GIP – providing https://tirzepatidepeptide035906.tusblogos.com/42701286/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment